← Back to Influence Map
Insulin Price Caps - State-Level Legislation
EnactedOver 25 states passed laws capping out-of-pocket insulin costs, typically at $25-35 per month. Major manufacturers (Lilly, Novo Nordisk, Sanofi) voluntarily capped prices after public pressure.
Who took a position
Supporting and opposing lists hold cited positions only. Lobbying filings say an entity lobbied on the measure, not which way. Positions the ingest inferred from donations are not positions and are listed separately below as giving to the legislators who voted.
Lobbied on (53)
- Sixteen Thirty Fund
- AARP
- BLUECROSS BLUESHIELD OF TENNESSEE
- National Retail Federation
- BLUE CROSS BLUE SHIELD OF MICHIGAN
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- KAISER FOUNDATION HEALTH PLAN INC
- JOHNSON & JOHNSON SERVICES INC
- AMERIHEALTH CARITAS
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
- GUIDEWELL MUTUAL HOLDING CORPORATION
- HIGHMARK INC
- and 41 more
Supporting (1)
Opposing (0)
- No opposing positions recorded.